Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
- PMID: 32931711
- PMCID: PMC7737584
- DOI: 10.1164/rccm.202007-2913LE
Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
Comment on
-
Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.Am J Respir Crit Care Med. 2020 Dec 15;202(12):1731-1733. doi: 10.1164/rccm.202006-2511LE. Am J Respir Crit Care Med. 2020. PMID: 32931713 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
